Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center.
grading
management
multidisciplinary
neuroendocrine tumors
outcome
staging
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 Jun 2019
25 Jun 2019
Historique:
received:
27
05
2019
revised:
20
06
2019
accepted:
21
06
2019
entrez:
28
6
2019
pubmed:
28
6
2019
medline:
28
6
2019
Statut:
epublish
Résumé
Multidisciplinary approach is widely advised for an effective care of patients with neuroendocrine neoplasia (NEN). Since data on efficacy of multidisciplinary management of NENs patients in referral centers are scanty, this study aimed at analyzing the modality of presentation and clinical outcome of patients with NENs managed by a dedicated multidisciplinary team. In this prospective observational study, we included all consecutive new patients visiting the Sant'Andrea Hospital in Rome (ENETS-Center of Excellence) between January 2014 and June 2018. A total of 195 patients were evaluated. The most frequent sites were pancreas (38.5%), small bowel (22%), and lung (9.7%). Median Ki67 was 3%. After the first visit at the center, additional radiological and/or nuclear medicine procedures were requested in 163 patients (83.6%), whereas histological data revision was advised in 84 patients (43.1%) (revision of histological slides: 27.7%, new bioptic sampling: 15.4%). After that, disease imaging staging and grading was modified in 30.7% and 17.9% of patients, respectively. Overall, a change in therapeutic management was proposed in 98 patients (50.3%). Multidisciplinary approach in a dedicated team may lead to change of disease imaging staging and grading in a significant proportion of patients. Enhancing referral routes to dedicated-NEN center should be promoted, since it may improve patients' clinical outcome.
Identifiants
pubmed: 31242670
pii: jcm8060910
doi: 10.3390/jcm8060910
pmc: PMC6616416
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Natl Cancer Inst. 2013 Jan 16;105(2):113-21
pubmed: 23274388
Neuroendocrinology. 2019;108(1):5-6
pubmed: 30517944
Neuroendocrinology. 2017 Feb 11;105(3):196-200
pubmed: 28190015
Ann Oncol. 2015 Aug;26(8):1604-20
pubmed: 25646366
Neuroendocrinology. 2018;107(1):42-49
pubmed: 29550809
CA Cancer J Clin. 2018 Nov;68(6):471-487
pubmed: 30295930
Q J Nucl Med Mol Imaging. 2017 Jun;61(2):153-167
pubmed: 28347132
Eur J Cancer. 2007 Apr;43(6):1002-10
pubmed: 17329094
Pancreas. 2014 Mar;43(2):212-8
pubmed: 24518498
Virchows Arch. 2007 Oct;451(4):757-62
pubmed: 17674042
Pancreas. 2013 May;42(4):557-77
pubmed: 23591432
J Clin Endocrinol Metab. 2017 May 1;102(5):1486-1494
pubmed: 28324047
Intern Med J. 2019 Oct;49(10):1268-1277
pubmed: 31062490
Oncologist. 2017 Apr;22(4):409-415
pubmed: 28232598
Eur J Surg Oncol. 2014 Nov;40(11):1517-22
pubmed: 25088936
J Oncol Pract. 2010 Nov;6(6):e11-6
pubmed: 21358944
Ann N Y Acad Sci. 2004 Apr;1014:222-33
pubmed: 15153439
Q J Nucl Med Mol Imaging. 2018 Dec;62(4):385-403
pubmed: 29869484
Neuroendocrinology. 2018;107(4):375-386
pubmed: 30300897
J Thorac Dis. 2017 Nov;9(Suppl 15):S1501-S1510
pubmed: 29201453
Br J Cancer. 2005 Oct 31;93(9):977-8
pubmed: 16234818
Endocr Relat Cancer. 2005 Dec;12(4):1083-92
pubmed: 16322345
Virchows Arch. 2006 Oct;449(4):395-401
pubmed: 16967267
Neuroendocrinology. 2017 Feb 17;105(3):310-319
pubmed: 28222443
Dig Liver Dis. 2011 Mar;43 Suppl 4:S356-60
pubmed: 21459341
Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):306-13
pubmed: 22760514
Clin Nucl Med. 2018 Nov;43(11):802-810
pubmed: 30247209
PLoS One. 2017 Jun 23;12(6):e0179445
pubmed: 28644861
Q J Nucl Med Mol Imaging. 2018 Mar;62(1):56-77
pubmed: 29191000
Adv Med Sci. 2016 Mar;61(1):147-53
pubmed: 26774266
World J Nucl Med. 2019 Apr-Jun;18(2):160-170
pubmed: 31040748